Nandabalan Krishnan
- SEC CIK
- 0001733387
No open-market purchases or sales filed in the past year.
Current role at each company
- BTAIQ BioXcel Therapeutics, Inc.Director, 10% Owneras of Apr 10, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Nandabalan Krishnan as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 10, 2023 (view filing)6:20 PM ET | Apr 6 | 4 days | Nandabalan KrishnanDirector, 10% Owner | SSale | −60.0K | $17.32 | −$1.04M | −100.0%0 after | 10b5-1 |
| Jan 6, 2023 (view filing)8:00 PM ET | Jan 4-5 | 2 days | Nandabalan KrishnanDirector, 10% Owner | SSale | −60.0K | $22.01 | −$1.32M | −100.0%0 after | 4 lots |
| Nov 14, 2022 (view filing)8:00 PM ET | Nov 10-11 | 4 days | Nandabalan KrishnanDirector, 10% Owner | SSale | −60.0K | $15.00 | −$900.0K | −100.0%0 after | 2 lots |